MedTrace Logo

Transplantation of Acellular Corneal Matrix to Treat Corneal Ulcer

NCT01244776 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2011-05-06

No results posted yet for this study

Summary

This study is to develop a lamellar keratoplasty method for corneal ulcer using acellular corneal matrix (ACM) and to make an analysis among patients for its therapeutic effect.

Conditions

  • Corneal Ulcer

Interventions

DEVICE

acellular corneal matrix

Efficacy of acellular corneal matrix to restore stroma integrity and treat corneal ulcer after lamellar keratoplasty.

Sponsors & Collaborators

  • Shenzhen AiNear Cornea Engineering Company Limited

    collaborator UNKNOWN

  • Air Force Military Medical University, China

    collaborator OTHER

  • Engineering Technology Center for Tissue Engineering of Xi'an

    collaborator UNKNOWN

  • Beijing Tongren Hospital

    collaborator OTHER

  • West China Hospital

    collaborator OTHER

  • Henan Provincial People's Hospital

    collaborator OTHER

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    collaborator OTHER

  • Southwest Hospital, China

    collaborator OTHER

  • Shaanxi Aierfu Activtissue Engineering

    lead INDUSTRY

Principal Investigators

  • Liuhe Zhou, M.D. · Beijing Tongren Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2011-12-31
Completion
2012-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01244776 on ClinicalTrials.gov